- Bevorzugter Name
- Batefenterol Succinate
- IUPAC
- butanedioic acid;[1-[3-[2-chloro-4-[[[(2R)-2-hydroxy-2-(8-hydroxy-2-oxo-1H-quinolin-5-yl)ethyl]amino]methyl]-5-methoxyanilino]-3-oxopropyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate
- Englischer Name
- Batefenterol Succinate
- Summenformel
- C44H48ClN5O11
- Molmasse
- 858.34
Namen und Synonyme
Batefenterol Succinate945905-37-3Batefenterol succinate [USAN]GSK961081DGSK-961081DUNII-552KVF22JT552KVF22JTBatefenterol succinate (USAN)BATEFENTEROL SUCCINATE [WHO-DD]1-(3-((2-CHLORO-4-((((2R)-2-HYDROXY-2-(8-HYDROXY-2-OXO-1,2-DIHYDROQUINOLIN-5-YL)ETHYL)AMINO(METHYL)-5-METHOXYPHENYL)AMINO)-3-OXOPROPYL)PIPERIDIN-4-YL (BIPHENYL-2-YL)CARBAMATE, BUTANEDIOATE (SALT)RefChem:116653SCHEMBL1999609
Weitere Namen anzeigen
961081TD-5959GSK-961081GSK-961081,Batefenterol succinate945905-37-3(Batefenterol succinate)[1-[3-[2-chloro-4-[[[(2R)-2-hydroxy-2-(8-hydroxy-2-oxo-1H-quinolin-5-yl)ethyl]amino]methyl]-5-methoxyanilino]-3-oxopropyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate
CHEMBL3039512SCHEMBL29380164BDWHLFQPZLPCIZ-XLQCLRHOSA-NGLXC-15738EX-A1732Batefenterol succinate, >98% (HPLC)GSK-961081; Batefenterol Succinate(R)-1-(3-((2-chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate succinate